| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/10/2004 | CA2512886A1 Ligands that modulate lxr-type receptors |
| 09/09/2004 | US20040176605 Compounds as antumor agents or immunosuppressants |
| 09/09/2004 | US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 09/09/2004 | US20040176601 Benzimisazo[4,5-f]isoquinolinone derivatives |
| 09/09/2004 | US20040176598 Azaindoles coupled with piperidine or piperazine and linker to cyclic group |
| 09/09/2004 | US20040176597 Pharmaceutical intermediates; nitrogen and oxygen fused heterocycles |
| 09/09/2004 | US20040176593 Cyclic diamine compounds used as drugs and chemical intermediates |
| 09/09/2004 | US20040176591 Novel synthesis and crystallization of peperazine ring-containing compounds |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176406 Pyrido [2,1-a] isoquinoline derivatives |
| 09/09/2004 | US20040176405 Methods and compounds for inhibitting MRP1 |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176396 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 09/09/2004 | US20040176390 Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176367 1-Amino 1H-imidazoquinolines |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176362 Matrix metalloproteinase inhibitors, treatment of tumor necrosis factor mediated diseases; autoimmune and neurodegenerative disorders; anticarcinogenic and antiinflammatory agents |
| 09/09/2004 | US20040176361 2H-Isoquinolin-1-one derivatives as poly/ADP-ribose/ polymerase inhibitors |
| 09/09/2004 | US20040176353 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/09/2004 | US20040176346 Cytostatic lanthanum compounds |
| 09/09/2004 | US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040174520 Low resolution surface enhanced raman spectroscopy on sol-gel substrates |
| 09/08/2004 | EP1454907A1 Quninazoline and pyridopyrmidine derivatives |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1453836A1 1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A 2a RECEPTOR ANTAGONISTS |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453831A1 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides |
| 09/08/2004 | EP1453830A1 Pyrazolo-pyridine derivatives as antiherpes agents |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453825A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor |
| 09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 09/08/2004 | EP1453800A2 Protein kinase inhibitors |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453511A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 09/08/2004 | EP1453506A2 Topoisomerase poison agents |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1268408B1 Arthropodicidal carboxanilides |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP1140933B1 Process for preparing n6-substituted deaza-adenosine derivatives |
| 09/08/2004 | EP0824524B1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
| 09/08/2004 | CN1527864A Perylene pigment compositions |
| 09/08/2004 | CN1527832A Europium compounds and ink compositions containing the same |
| 09/08/2004 | CN1527831A Antagonists of MCP-q function and method of use thereof |
| 09/08/2004 | CN1527712A Active ingredient combination for medicamentous therapy of nicotine dependency |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1165537C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists |
| 09/08/2004 | CN1165536C Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 09/08/2004 | CN1165535C Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 09/08/2004 | CN1165526C Substituted phenyl cyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
| 09/07/2004 | US6787569 Therapeutic guanidines |
| 09/07/2004 | US6787556 Benzoic acid derivatives for the treatment of diabetes mellitus |
| 09/07/2004 | US6787554 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives |
| 09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
| 09/07/2004 | US6787547 Compound and method for the treatment of pain |
| 09/07/2004 | US6787534 Sulfonamide-containing heterocyclic compounds |
| 09/02/2004 | WO2004074812A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004074290A1 Substituted amino heterocycles as vr-1 antagonists for treating pain |
| 09/02/2004 | WO2004074286A1 Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/02/2004 | WO2004074285A1 The enantiomer of tenatoprazole and the use thereof in therapy |
| 09/02/2004 | WO2004074284A1 Oxazole-derivatives as ppar agonists |
| 09/02/2004 | WO2004074283A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors |
| 09/02/2004 | WO2004074278A1 Novel compounds |
| 09/02/2004 | WO2004074276A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 09/02/2004 | WO2004074274A1 Substituted n-aryl nitrogen heterocycles |
| 09/02/2004 | WO2004074273A1 Novel compounds |
| 09/02/2004 | WO2004074270A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 09/02/2004 | WO2004074248A2 Isolation and structure of cribrostatin 6 |
| 09/02/2004 | WO2004074246A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004073628A2 Novel compounds |
| 09/02/2004 | WO2004073615A2 Deazaflavin compounds and methods of use thereof |
| 09/02/2004 | WO2004056362A3 8-trialkysyloxy-2-methyl-9-phenyl-7-0 xo-7,8,9,10- tetrahydroimidazo ‘1,2-h! ‘1,7! naphthyridines |
| 09/02/2004 | WO2004056324A3 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/02/2004 | WO2004056319A3 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 09/02/2004 | WO2004050036A3 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 09/02/2004 | WO2004048377A3 Method of preparing inhibitors of phosphodiesterase-4 |
| 09/02/2004 | WO2004035569A3 Novel compounds with antibacterial activity |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS |
| 09/02/2004 | US20040171832 Novel sulfonate substituted pyrazol pyridine derivatives |
| 09/02/2004 | US20040171830 Carboline derivatives as pdev inhibitors |
| 09/02/2004 | US20040171828 Respiratory system disorders; asthma; antihistamines |
| 09/02/2004 | US20040171638 Chemokine receptor binding heterocyclic compounds |
| 09/02/2004 | US20040171633 (1, 8) naphthyridines as gaba ligands, their pharmaceutical compositions and uses |
| 09/02/2004 | US20040171630 both receptor-type and non-receptor type tyrosine kinases; to treat angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, |
| 09/02/2004 | US20040171620 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
| 09/02/2004 | US20040171607 Chemical compounds |
| 09/02/2004 | US20040171606 antagonism/inhibition, of the D3 receptor; substance abuse. |
| 09/02/2004 | US20040171587 novel substituted pyridines; upon in vivo administration, reduced the deleterious effect of traumatic CNS tissue injury though restoration of nerve impulse conduction through nerve tissue lesions |
| 09/02/2004 | US20040171477 Synthesis of ITQ-17 in the absence of fluoride ions |
| 09/02/2004 | US20040170980 Molecules capable of binding to telomere and the like and method with the use of the same |
| 09/02/2004 | US20040170863 Organic electroluminescent devices using double-spiro organic compounds |
| 09/02/2004 | US20040170573 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 09/02/2004 | US20040170569 Dosage forms that rapidly produces peak plasma concentrations; heating a thin layer of the drug on a solid support to form a vapor; and passing air through the heated vapor to produce aerosol particles having less than 10% drug degradation products |